Advancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Breast Cancer: Expert-Led Training and Resources for the Interprofessional Team

Gain insights for identifying patients with high-risk, localized and newly diagnosed advanced HR-positive/HER2-negative breast cancer along with corresponding treatment recommendations and adverse event management guidance, through on-demand webcasts, downloadable slides, podcasts, an interactive decision support tool, and a downloadable patient resource.

Share

Program Content

Events

Activities

Individualizing EBC Therapy
Individualizing Adjuvant Therapy for HR-Positive/HER2-Negative Early Breast Cancer in Your Practice
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 01, 2025

Expires: March 31, 2026

Individualizing MBC Therapy
Individualizing Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer in Your Practice
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 01, 2025

Expires: March 31, 2026

Activities

CDK46i Thriving During Treatment
Navigating Your Journey With CDK4/6 Inhibitors: A Guide for Thriving During Treatment
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 24, 2025

Expires: March 23, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This activity is supported by an educational grant from Lilly.

Lilly